Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan

Infection, Genetics and Evolution

Volumn 9, Issue 5, 2009, Pages 778-783

  Al Saai, Salma ^a   Kheir, Amani ^b   Abdel Muhsin, Abdel Muhsin A ^c   Al Ghazali, Aisha ^a   Nwakanma, Davis ^d   Swedberg, Göte ^b   Babiker, Hamza A ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b UPPSALA UNIVERSITY   (Sweden)

^c Tropical Medicine Research Institute   (Sudan)

^d Medical Research Laboratories   (Gambia)

Author keywords

dhfr; dhps haplotypes; Evolution; Plasmodium falciparum; Pyrimethamine; Sudan; Sulfadoxine resistance

Indexed keywords

ARGININE; ASPARAGINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR; ISOLEUCINE; LEUCINE; SERINE;

ADULT; ARTICLE; CHILD; CHROMOSOME 4; CHROMOSOME 8; CONTROLLED STUDY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; NONHUMAN; PARASITE ISOLATION; PHARMACOGENETICS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTOZOAL GENETICS; SUDAN;

ANIMALS; ANTIMALARIALS; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE; ENDEMIC DISEASES; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; MICROSATELLITE REPEATS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; PYRIMETHAMINE; SUDAN; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

PLASMODIUM FALCIPARUM;

EID: 67651100659     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2009.04.010     Document Type: Article

References (50)

1. Abbott P.H. Trials with Camoquine and Daraprim in treatment of malaria at Wad Medani, Sudan. J. Sud. Med. Ass. 3 (1955) 33-38
2. Abdel-Muhsin A., Mackinnon M., Awadalla P., Ali E., Suleiman S., Ahmed S., Walliker D., and Babiker H.A. Local differentiation in Plasmodium falciparum drug resistance genes in Sudan. Parasitology 126 (2003) 391-400
3. Abdel-Muhsin A.A., Mackinnon M., Ali E., Nassir E., Suleiman S., Ahmed S., Walliker D., and Babiker H.A. Evolution of drug resistance genes in Plasmodium falciparum in an area of seasonal transmission in eastern Sudan: implication for control. J. Infect. Dis. 189 (2004) 1239-1244
4. Abdel-Muhsin A.M., Ranford-Cartwright L.C., Medani A.R., Ahmed S., Suleiman S., Khan B., Hunt P., Walliker D., and Babiker H.A. Detection of mutations in Plasmodium falciparum dihydrofolate reductase (dhfr) by dot-blot hybridisation. Am. J. Trop. Med. Hyg. 67 (2002) 24-27
5. A-Elbasit I.E., Elbashir M.I., Khalil I.F., Alifrangis M., and Giha H.A. The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis. Trop. Med. Int. Health 11 (2006) 604-612
6. A-Elbasit I.E., Khalil I.F., Elbashir M.I., Masuadi E.M., Bygbjerg I.C., Alifrangis M., and Giha H.A. High frequency of Plasmodium falciparum CICNI/SGEAA and CVIET haplotypes without association with resistance to sulfadoxine/pyrimethamine and chloroquine combination in the Daraweesh area, in Sudan. Eur. J. Clin. Microbiol. Infect. Dis. 27 (2008) 725-732
7. Ahmed A.A., Osman H., Mansour A.M., Musa H.A., Ahmed A.B., Karrar Z., and Hassan H.S. Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan. Am. J. Trop. Med. Hyg. 63 November-December (5-6) (2000) 259-263
8. Alano P., Read D., Bruce M., Aikawa M., Kaido T., Tegoshi T., Bhatti S., Smith D.K., Luo C., Hansra S., Carter R., and Elliott J.F. Cos cell expression cloning of Pfg377, a Plasmodium falciparum gametocyte antigen associated with osmiophilic bodies. Mol. Biochem. Parasitol. 74 (1995) 143-156
9. Ali E., Mackinnon M., Abdel-Muhsin A., Ahmed S., Walliker D., and Babiker H.A. Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 176-183
10. Anderson T.J., Haubold B., Williams J.T., Estrada-Franco J.G., Richardson L., Mollinedo R., Bockarie M., Mokili J., Mharakurwa S., French N., Whitworth J., Velez I.D., Brockman A.H., Nosten F., Ferreira M.U., and Day K.P. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol. Biol. Evol. 17 (2000) 1467-1482
11. Anderson T.J., Nair S., Jacobzone C., Zavai A., and Balkan S. Molecular assessment of drug resistance in Plasmodium falciparum from Bahr El Gazal province, Sudan. Trop. Med. Int. Health 8 (2003) 1068-1073
12. Babiker H.A., Creasey A.M., Bayoumi R.A., Walliker D., and Arnot D.E. Genetic diversity of the human malaria parasite Plasmodium falciparum in a village in Eastern Sudan. II. Drug resistance, molecular karyotypes and the mdr-1 genotype in recent field isolates. Trans. R. Soc. Trop. Med. Hyg. 85 (1991) 578-583
13. Babiker H.A., Satti G., and Walliker D. Genetic changes in the population of Plasmodium falciparum population in a Sudanese village over three year period. Am. J. Trop. Med. Hyg. 53 (1995) 7-15
14. Babiker H.A., Satti G., Ferguson H.M., Bayoumi R., and Walliker D. Drug resistant Plasmodium falciparum in an area of seasonal transmission. Acta Trop. 94 (2005) 260-268
15. Binks R.H., Baum J., Oduola A.M.J., Arnot D.E., Babiker H.A., Kremsner P.G., Roper C., Greenwood B.M., and Conway D.J. Population genetic analysis of the Plasmodium falciparum erythrocyte binding antigen-17 (eba-175) gene. Mol. Biochem. Parasitol. 114 (2001) 63-70
16. Certain L.K., Briceño M., Kiara S.M., Nzila A.M., Watkins W.M., and Sibley C.H. Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance Kilifi, Kenya, 1987-2006. J. Infect. Dis. 197 (2008) 1743-1751
17. Chen G.X., Mueller C., Wendlinger M., and Zolg J.W. Kinetic and molecular properties of the dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant clones of the human malaria parasite Plasmodium falciparum. Mol. Pharmacol. 31 (1987) 430-437
18. Cortese J.F., Caraballo A., Contreras C.E., and Plowe C.V. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J. Infect. Dis. 186 (2002) 999-1006
19. Ferlan J.T., Mookherjee S., Okezie I.N., Fulgence L., and Sibley C.H. Mutagenesis of dihydrofolate reductase from Plasmodium falciparum: analysis in Saccharomyces cerevisiae of triple mutant alleles resistant to pyrimethamine or WR99210. Mol. Biochem. Parasitol. 113 (2001) 139-150
20. Gesase S., Gosling R.D., Hashim R., Ord R., Naidoo I., Madebe R., Mosha J.F., Joho A., Mandia V., Mrema H., Mapunda E., Savael Z., Lemnge M., Mosha F.W., Greenwood B., Roper C., and Chandramohan D. High resistance of Plasmodium falciparum to sulphadoxine/ pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS ONE 4 2 (2009) e4569
21. Hamad A., Nugud A.D., Arnot D., Abdel-Muhsin A.A., Giha H., Satti G., Theander T., Creasey A., Babiker H.A., and ELnaiem D. Marked seasonality of malaria transmission in two rural sites in eastern Sudan. Acta Trop. 83 (2002) 71-82
22. Hyde J.E. The dihydrofolate reductase-thymidylate synthase gene in the drug resistance of malaria parasites. Pharmacol. Ther. 48 (1990) 45-59
23. Khalil I., Alifrangis A.M., Rønn H.A., Gabar T., Jelinek G.M., Satti I.C., and Bygbjerg. Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome. Am. J. Trop. Med. Hyg. 67 (2002) 225-229
24. Khalil I.F., Rønn A.M., Alifrangis M., Gabar H.A., Jelinek T., Satti G.M., and Bygbjerg I.C. Response of Plasmodium falciparum to cotrimoxazole therapy: relationship with plasma drug concentrations and dihydrofolate reductase and dihydropteroate synthase genotypes. Am. J. Trop. Med. Hyg. 73 (2005) 74-77
25. Kublin J.G., Dzinjalamala F.K., Kamwendo D.D., Malkin E.M., Cortese J.F., Martino L.M., Mukadam R.A.G., Rogerson S.J., Lescano A.G., Molyneux M.E., Winstanley P.A., Chimpeni P., Taylor T.E., and Plowe C.V. Molecular markers for failure of sulfadoxine-pyrimethamine and chloroproquanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185 (2002) 380-388
26. Mackinnon M.J., and Hastings I.M. The evolution of multiple drug resistance in malaria parasites. Trans. R. Soc. Trop. Med. Hyg. 92 (1998) 188-195
27. Maïga O., Djimdé A.A., Hubert V., Renard E., Aubouy A., Kironde F., Nsimba B., Koram K., Doumbo O.K., Le Bras J., and Clain J.A. Shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J. Infect. Dis. 196 (2007) 165-172
28. Malik E.M., Mohamed T.A., Elmardi K.A., Mowien R.M., Elhassan A.H., Elamin S.B., Mannan A.A., and Ahmed E.S. From chloroquine to artemisinin-based combination therapy: the Sudanese experience. Malar. J. 31 5 (2006) 65
29. McCollum A.M., Poe A.C., Hamel M., Huber C., Zhou Z., Shi Y.P., Ouma P., Vulule J., Bloland P., Slutsker L., Barnwell J.W., Udhayakumar V., and Escalante A.A. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J. Infect. Dis. 194 (2006) 189-197
30. McCollum A.M., Mueller K., Villegas L., Udhayakumar V., and Escalante A.A. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. Antimicrob. Agents Chemother. 51 (2007) 2085-2091
31. McCollum A.M., Basco L.K., Tahar R., Udhayakumar V., and Escalante A.A. Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from central Africa. Antimicrob. Agents Chemother. 52 (2008) 4089-4097
32. Mehlotra R.K., Mattera G., Bockarie M.J., Maguire J.D., Baird J.K., Sharma Y.D., Alifrangis M., Dorsey G., Rosenthal P.J., Fryauff D.J., Kazura J.W., Stoneking M., and Zimmerman P.A. Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. Antimicrob. Agents Chemother. 52 June (6) (2008) 2212-2222
33. Nair S., Williams J.T., Brockman A., Paiphun L., Mayxay M., Newton P.N., Guthmann J.P., Smithuis F.M., Hien T.T., White N.J., Nosten F., and Anderson T.J. A selective sweep driven by pyrimethamine treatment in southeast Asian malaria parasites. Mol. Biol. Evol. 20 (2003) 1526-1536
34. Nash D., Nair S., Mayxay M., Newton P.N., Guthmann J.P., Nosten F., and Anderson T.J. Selection strength and hitchhiking around two anti-malarial resistance genes. Proc. Biol. Sci. 272 (2005) 1153-1161
35. Nassir E., Abdel-Muhsin A.M., Suliaman S., Kenyon F., Kheir A., Geha H., Ferguson H.M., Walliker D., and Babiker H.A. Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. Int. J. Parasitol. 35 (2005) 49-55
36. Ndiaye D., Daily J.P., Sarr O., Ndir O., Gaye O., Mboup S., Roper C., and Wirth D.F. Defining the origin of Plasmodium falciparum resistant dhfr isolates in Senegal. Acta Trop. 99 (2006) 106-111
37. Payne D. Spread of chloroquine resistance in Plasmodium falciparum. Parasitol. Today 8 (1987) 241-246
38. Peterson D.S., Walliker D., and Wellems T.E. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9114-9118
39. Plowe C.V., Djimde A., Bouare M., Doumbo O., and Wellems T.E. Pyrimethamine and proguanil resistance conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am. J. Trop. Med. Hyg. 52 (1995) 565-568
40. Plowe C.V., Cortese J.F., Djimde A., Nwanyanwu O.C., Watkins W.M., Winstanley P.A., Estrada-Franco J.G., Mollinedo R.E., Avila J.C., Cespedes J.L., Carter D., and Doumbo O.K. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J. Infect. Dis. 176 (1997) 1590-1596
41. Plowe C.V., Kublin J.G., and Doumbo O.K. P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates. Drug Resist. Updat. 1 6 (1998) 389-396
42. Raymond M., and Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J. Heredity 86 (1995) 248-249
43. Roper C., Pearce R., Bredenkamp B., Gumede J., Drakeley C., Mosha F., Chandramohan D., and Sharp B. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet 361 9364 (2003) 1174-1181
44. Roper C., Pearce R., Nair S., Sharp B., Nosten F., and Anderson T.J. Intercontinental spread of pyrimethamine resistant malaria. Science 305 (2004) 1124
45. Su X., Ferdig M.T., Huang Y., Huynh C.Q., Liu A., You J., Wootton J.C., and Wellems T.E. Genetic map and recombination parameters of the human malaria parasite P. falciparum. Science 286 (1999) 1351-1353
46. Triglia T., Wang P., Sims P.F., Hyde J.E., and Cowman A.F. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO J. 17 (1998) 3807-3815
47. Wang P., Nirmalan N., Wang Q., Sims P.F., and Hyde J.E. Genetic and metabolic analysis of folate salvage in the human malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 135 (2004) 77-87
48. White N.J. Delaying antimalarial drug resistance with combination chemotherapy. Parasitologia 41 (1999) 301-308
49. Wootton J.C., Feng X., Ferdig M.T., Cooper R.A., Mu J., Baruch D.I., Magill A.J., and Su X.Z. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418 (2002) 320-323
50. Yuvaniyama J., Chitnumsub P., Kamchonwongpaisan S., Vanichtanankul J., Sirawaraporn W., Taylor P., Walkinshaw M.D., and Yuthavong Y. Insights into antifolate resistance from malarial DHFR-TS structures. Nat. Struct. Biol. 10 (2003) 357-365